Combating CoV infections is a massive concern for healthcare systems, owing to the virus's high transmission rate and ability to withstand several mutations. The use of nanotechnology in the diagnosis, treatment, and prevention of COVID-19 has enormous potential. Several nano-based formulations have been demonstrated to increase antiviral medication target delivery and therapeutic efficacy. A new generation of vaccines based on various types of nanomaterials, with better antigen stability, target delivery, and controlled-release, is another promising alternative. The development of technologies for speedy, accurate, and sensitive diagnosis, the manufacturing of effective disinfectants, the delivery of mRNA vaccines into human cells, and the delivery of antiviral medicines into the body are all nanotechnology-based solutions for COVID-19 disease management.
Title : Recent advances in nanomedicine: Sensors, implants, artificial intelligence, saving the environment, human studies, and more
Thomas J Webster, Hebei University of Technology, China
Title : Harnessing the unique transport properties of InAs nanowires for single molecule level sensing
Harry E Ruda, University of Toronto, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Success in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University, Australia
Title : Photonic metasurfaces in azobenzene materials
Ribal Georges Sabat, Royal Military College of Canada, Canada
Title : Microplastics and nanoplastics in Antartica. Consideration their impact on ecosystems and human and fauna health
Maria Cecilia Colautti, Defense University of Republic of Argentina, Argentina